Relationship between quality of care and racial disparities in medicare health plans

JAMA

Volumn 296, Issue 16, 2006, Pages 1998-2004

  Trivedi, Amal N ^a   Zaslavsky, Alan M ^b   Schneider, Eric C ^b,c   Ayanian, John Z ^b,c,d  

^a BROWN UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A; LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 33750309511     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.16.1998     Document Type: Article

References (48)

1. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283:2579-2584.
2. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
3. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
4. Ayanian JZ, Weissman JS, Chasan-Taber S, Epstein AM. Quality of care by race and gender for congestive heart failure and pneumonia. Med Care. 1999;37:1260-1269.
5. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in Medicare managed care. JAMA. 2002;287:1288-1294.
6. Schneider EC, Cleary PD, Zaslavsky AM, Epstein AM. Racial disparity in influenza vaccination. JAMA. 2001;286:1455-1460.
7. Virnig BA, Lurie N, Huang Z, et al. Racial variation in quality of care among Medicare + Choice enrollees. Health Aff (Millwood). 2002;21:224-230.
8. Hannan EL, Kilburn H Jr, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271:761-766.
9. Schneider EC, Riehl V, Courte-Wienecke S, Eddy DM, Sennett C; National Committee for Quality Assurance. Enhancing performance measurement: NCQA's road map for a health information framework. JAMA. 1999;282:1184-1190.
10. Jha AK, Li Z, Orav EJ, Epstein AM. Care in US hospitals - the Hospital Quality Alliance program. N Engl J Med. 2005;353:265-274.
11. Schneider EC, Zaslavsky AM, Landon BE, Lied TR, Sheingold S, Cleary PD. National quality monitoring of Medicare health plans. Med Care. 2001;39:1313-1325.
12. Moy E, Dayton E, Clancy CM. Compiling the evidence: the National Healthcare Disparities Reports. Health Aff (Millwood). 2005;24:376-382.
13. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare Managed Care. N Engl J Med. 2005;353:692-700.
14. Health Care Financing Administration, US Department of Health and Human Services. Medicare HEDIS 3.0/1998 Data Audit Report. http://permanent.access. gpo.gov/websites/www.hcfa.gov/quality/3i2.htm. Accessed October 5, 2006.
15. Sequist TD, Schneider EC. Addressing racial and ethnic disparities in health care. Health Serv Res. 2006;41:1451-1468.
16. Arday SL, Arday DR, Monroe S, Zhang J. HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev. 2000;21:107-116.
17. The InterStudy Competitive Edge 12.1 [database]. St Paul, Minn: InterStudy Publications; 2001.
18. Agency for Healthcare Research and Quality. CAHPS 3.0 Health Plan Survey and Reporting Kit. Rockville, Md: Agency for Healthcare Research and Quality; 2005.
19. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955-1964.
20. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35:539-543.
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
22. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837-853.
23. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
24. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
25. The Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349-1357.
26. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. Lancet. 2003;361:2005-2016.
27. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006;354:1147-1154.
28. Ma J, Stafford RS. Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med. 2005;165:1354-1361.
29. Sehgal AR. Impact of quality improvement efforts on race and sex disparities in hemodialysis. JAMA. 2003;289:996-1000.
30. Sequist TD, Adams AS, Zhang F, Ross-Degnan D, Ayanian JZ. The effect of quality improvement on racial disparities in diabetes care. Arch Intern Med. 2006;166:675-681.
31. Mangione CM, Gerzoff RB, Williamson DF, et al. The association between quality of care and intensity of diabetes management programs. Ann Intern Med. 2006;145:107-116.
32. O'Connor PJ, Desai J, Solberg LI, et al. Randomized trial of quality improvement intervention to improve diabetes care in primary car settings. Diabetes Care. 2005;28:1890-1897.
33. America's Health Insurance Plans and The Robert Wood Johnson Foundation. Collection of racial and ethnic data by health plans to address disparities: final summary report. http://www.rwjf.org/files/research/080504AHIPFinalSummary. pdf. Accessed October 5, 2006.
34. Zaslavsky AM, Ayanian JZ. Integrating research on racial and ethnic disparities in health care over place and time. Med Care. 2005;43:303-307.
35. Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005;43:308-319.
36. Bradley EH, Herrin J, Wang Y, et al. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004;292:1563-1572.
37. Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation. 2005;112:2634-2641.
38. Gandhi TK, Francis EC, Puopolo AL, Burstin HR, Haas JS, Brennan TA. Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care. 2002;40:155-165.
39. Lurie N, Zhan C, Sangl J, et al. Variation in racial and ethnic differences in consumer assessments of health care. Am J Manag Care. 2003;9:502-509.
40. Lee TH, Cleeman JI, Grundy SM, et al. Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease. JAMA. 2000;283:94-98.
41. Hofer TP, Hayward RA, Greenfield S, et al. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA. 1999;281:2098-2105.
42. Zaslavsky AM, Hochheimer JN, Schneider EC, et al. Impact of sociodemographic case mix on the HEDIS measures of health plan quality. Med Care. 2000;38:981-992.
43. Werner RM, Asch DA, Polsky D. Racial profiling: the unintendedconsequencesofcoronaryarterybypassgraft report cards. Circulation. 2005;111:1257-1263.
44. Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with "poor quality" actually getting good care? Med Care. 2003;41:1173-1182.
45. Ayanian JZ, Landrum MB, McNeil BJ. Use of cholesterol-lowering therapy by elderly adults after myocardial infarction. Arch Intern Med. 2002;162:1013-1019.
46. Persell SD, Maviglia S, Bates DW, Ayanian JZ. Ambulatory hypercholesterolemia management in patients with atherosclerosis. J Gen Intern Med. 2005;20:123-130.
47. Zaslavsky AM, Buntin MJ. Using survey measures to assess risk selection among Medicare managed care plans. Inquiry. 2002;39:138-151.
48. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.